### [Body Surface Area][BodySurfaceArea]

* [Body Surface Area - 0.27](Observation-body-surface-area-example.html)

### [Cancer Disease Status](StructureDefinition-mcode-cancer-disease-status.html)

* [Cancer Disease Status Improved](Observation-cancer-disease-status-improved.html)

### [Cancer Patient](StructureDefinition-mcode-cancer-patient.html)

* [Cancer Patient Adam](Patient-cancer-patient-adam-everyman.html)
* [Cancer Patient Eve](Patient-cancer-patient-eve-anyperson.html)
* [Cancer Patient John](Patient-cancer-patient-john-anyperson.html)

### [Cancer Related Medication Request](StructureDefinition-mcode-cancer-related-medication-request.html)

* [CisPlatin - ChemoInfusion](MedicationRequest-cancer-related-medication-request-cisplatin.html)
* [CisPlatin - ChemoInfusion - Stopped](MedicationRequest-cancer-related-medication-request-cisplatin-stopped.html)
* [GeFitinib - Oral Tablet](MedicationRequest-cancer-related-medication-request-gefitinib.html)

### [Cancer Related Surgical Procedure][CancerRelatedSurgicalProcedure]
* [Lobectomy](Procedure-cancer-related-surgical-procedure-lobectomy.html)

### [CancerStage - TNM][CancerStage]

* [TNM Clinical Distant Metastases Category - cM0](Observation-tnm-clinical-distant-metastases-category-cM0.html)
* [TNM Clinical Primary Tumor Category - cT3](Observation-tnm-clinical-primary-tumor-category-cT3.html)
* [TNM Clinical Regional Nodes Category - cN3](Observation-tnm-clinical-regional-nodes-category-cN3.html)
* [TNM Clinical Stage Group 3](Observation-tnm-clinical-stage-group-3c.html)
* [Prognostic Factor: Lab Result Hemoglobin](Observation-lab-result-observation-hemoglobin.html)

### [CancerStage - non-TNM][CancerStage]

* [Binet staging for chronic lymphocytic leukemia](Observation-binet-stage-group-B.html)
* [Rai staging for chronic lymphocytic leukemia](Observation-rai-stage-II.html)
* [Cotswold staging of Hodgkin's disease](Observation-hodgkins-lymphoma-stage-IIIe.html)
* [Gynecologic tumor staged by FIGO (International Federation of Gynecology and Obstetrics)](Observation-figo-stage-IIIA.html)
* [Melanoma Breslow Depth Stage](Observation-melanoma-breslow-depth-stage.html)
* [Melanoma Clark Level 4](Observation-melanoma-clark-level-4.html)
* [Myeloma stage by International Staging System (ISS)](Observation-multiple-myeloma-iss-stage-II.html)
* [Myeloma stage by Revised International Staging System (RISS)](Observation-multiple-myeloma-riss-stage-II.html)
* [Neuroblastoma INSS Stage III](Observation-neuroblastoma-inss-stage-III.html)
* [Neuroblastoma INRGSS Stage M](Observation-neuroblastoma-inrgss-stage-MS.html)
* [Prostate cancer graded by Gleason Grade Group](Observation-gleason-grade-group-4.html)
* [Rhabdomyosarcoma Clinical Group Stage IA](Observation-rhabdomyosarcoma-clinical-group-stage-IA.html)
* [Wilms Tumor Stage III](Observation-wilms-tumor-stage-III.html)

### [Comorbidities]

* [Cancer Related Comorbidities - John Anyperson](Observation-cancer-related-comorbidities-john-anyperson.html)
* [Congestive Heart Failure Condition](Condition-john-anyperson-chf.html)


### [Deauville Scale - Five][DeauvilleScale]

* [Deauville Scale - Five](Observation-deauville-scale-five.html)

### [ECOG Performance Status][ECOGPerformanceStatus]

* [ECOG Performance - Fully Active](Observation-ecog-performance-status-fully-active.html)

### [Genomic Region Studied][GenomicRegionStudied]

* [Genomic Region Studied - STK11](Observation-genomic-region-studied-stk11.html)

### [Genomics Report][GenomicsReport]

* [Genomic Diagnostic Report - John Anyperson](DiagnosticReport-genomics-report-john-anyperson.html)

### [History of Metastatic Cancer][HistoryOfMetastaticCancer]

* [History of Cancer Metastatic to Liver](Observation-history-of-cancer-metastatic-to-liver.html)
* [No History of Metastatic Cancer (explicit assertion)](Observation-no-history-of-metastatic-cancer.html)

### [Human Specimen][HumanSpecimen]

* [Human Specimen - Lung](Specimen-human-specimen-lung.html)
* [Human Specimen - Tumor](Specimen-tumor-specimen-lobular-carcinoma-left-breast.html)

### [Genomic Variant][GenomicVariant]

* [Genomic Variant - Gene Fusion](Observation-genomic-variant-fusion.html)
* [Genomic Variant - Single Nucleotide Change](Observation-genomic-variant-somatic-single-nucleotide.html)
* [Genomic Variant - Single Germline Deletion](Observation-genomic-variant-germline-deletion.html)

### [Histologic Behavior and Type][HistologicBehaviorAndType]

* [Histologic Behavior and Type - Non-Small Cell, Malignant, Primary Site](Observation-histologic-behavior-and-type-non-small-cell.html)

### [Histologic Grade][HistologicGrade]

* [Histologic Grade - Intermediate](Observation-histologic-grade-intermediate.html)

### [Karnofsky Performance Status][KarnofskyPerformanceStatus]

* [Karnofsky Performance State - Normal Activities](Observation-karnofsky-performance-status-normal-activity.html)

### [Lansky Play Performance Status][LanskyPlayPerformanceStatus]

* [Lansky Play Performance Status - 20](Observation-lansky-play-performance-status-twenty.html)

### [mCODE Patient Group][MCODEPatientGroup]

* [Group identifying in-scope patients](Group-group-mcode-patients.html)

### [Primary Cancer Condition][PrimaryCancerCondition]

* [Chronic lymphoid leukemia, Binet Stage A](Condition-primary-cancer-condition-cll.html)
* [Non-Small Cell Lung Cancer, Stage IIc](Condition-primary-cancer-condition-nsclc.html)
* [Post-coordination example with separate codes for morphology and bodySite](Condition-primary-cancer-condition-breast.html)

### [Radiotherapy Course Summary][RadiotherapyCourseSummary]

* [Radiotherapy summary with novel modality (neutron capture)](Procedure-radiotherapy-treatment-summary-other-with-text.html)

### [Radiotherapy Volume][RadiotherapyVolume]

* [Lower lobe of left lung](BodyStructure-john-anyperson-treatment-volume.html)

### [Risk Assessments][CancerRiskAssessment]

* [Rhabdomyosarcoma - Low Risk](Observation-rhabdomyosarcoma-risk-assessment-low.html)
* [All Risk Assessment - High Risk](Observation-all-risk-assessment-high.html)

### [Secondary Cancer Condition][SecondaryCancerCondition]

* [Brain Metastases](Condition-secondary-cancer-condition-brain-mets.html)

### [Tumor][Tumor]

* [Lobular tumor in left breast](BodyStructure-tumor-lobular-carcinoma-left-breast.html)

### [Tumor Marker Test][TumorMarkerTest]

* [Tumor Marker Test - Epidermal Growth Factor](Observation-tumor-marker-test-egf.html)

### [Tumor Morphology][TumorMorphology]

* [Tumor Morphology Report - Non-Small Cell Carcinoma, Malignant, Primary Site, Intermediate Grade](Observation-tumor-morphology-report-non-small-cell-intermediate-grade.html)

### [Tumor Size][TumorSize]

* [Tumor size by gross anatomy](Observation-tumor-size-pathology.html)


{% include markdown-link-references.md %}